Fetal bradycardia following intrauterine platelet transfusion: might elevated levels of donor soluble CD40 ligand play a role?

Acta Obstet Gynecol Scand. 2004 Sep;83(9):868-9. doi: 10.1111/j.0001-6349.2004.0148c.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Biomarkers / blood
  • Blood Donors
  • Blood Transfusion, Intrauterine / adverse effects
  • Blood Transfusion, Intrauterine / methods
  • Bradycardia / diagnosis
  • Bradycardia / etiology*
  • CD40 Ligand / analysis*
  • Erythroblastosis, Fetal / prevention & control*
  • Female
  • Follow-Up Studies
  • Gestational Age
  • Heart Rate, Fetal / drug effects*
  • Humans
  • Infant, Newborn
  • Platelet Transfusion / adverse effects*
  • Platelet Transfusion / methods
  • Pregnancy
  • Pregnancy Outcome*
  • Risk Assessment
  • Sensitivity and Specificity
  • Treatment Outcome

Substances

  • Biomarkers
  • CD40 Ligand